Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system

被引:91
作者
Kumar, Victoria A. [1 ]
Sidell, Margo A. [2 ]
Jones, Jason P. [2 ]
Vonesh, Edward F. [3 ]
机构
[1] So Calif Permanente Med Grp, Dept Internal Med, Div Nephrol, Los Angeles, CA 90027 USA
[2] So Calif Permanente Med Grp, Pasadena, CA USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
关键词
ESRD; hemodialysis; mortality risk; peritoneal dialysis; survival; RESIDUAL RENAL-FUNCTION; CHARLSON COMORBIDITY INDEX; DIALYSIS PATIENTS; MORTALITY RISK; SIMILAR OUTCOMES; IMPACT; COHORT; DEATH;
D O I
10.1038/ki.2014.224
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We sought to compare survival among incident peritoneal dialysis (PD) patients to matched hemodialysis (HD) patients who received pre-dialysis care, including permanent dialysis access placement. Patients starting PD were propensity matched to those starting HD. HD patients who used a central venous catheter during the first 90 days of dialysis were excluded. Stratified Cox proportional hazards models were used to compare patient survival using both intent-to-treat and as-treated analyses. In the intent-to-treat analysis, patients were followed from the date of first dialysis until death and censored at the earliest of the following: renal transplantation, death, renal recovery, loss to follow-up or study end. In the as-treated analysis, patients were also censored at the time of modality change. A total of 1003 matched pairs were obtained from 11,301 incident patients (10,298 HD and 1003 PD). The cumulative hazard ratio for death at one year was 2.38 (95% CI 1.68-3.40) and 2.10 (1.50-2.94) for HD relative to PD patients in the as-treated and intent-to-treat analyses, respectively. The cumulative risk of death, as estimated by the cumulative hazard ratio, favored PD for almost up to 3 years of follow-up in the as-treated analysis and nearly 2 years of follow-up in the intent-to-treat analysis with no differences thereafter. The higher adjusted rate of death observed for HD patients cannot be attributed to initial use of central venous catheters or lack of pre-dialysis care.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 42 条
[1]  
Acchiardo S R, 1983, Kidney Int Suppl, V16, pS199
[2]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[3]  
BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P177
[4]  
CANCARINI GC, 1986, PERITON DIALYSIS INT, V6, P77
[5]   Mortality risks of peritoneal dialysis and hemodialysis [J].
Collins, AJ ;
Hao, WL ;
Xia, H ;
Ebben, JP ;
Everson, SE ;
Constantini, EG ;
Ma, JZ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (06) :1065-1074
[6]   Practical considerations on the use of the Charlson comorbidity index with administrative data bases [J].
DHoore, W ;
Bouckaert, A ;
Tilquin, C .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) :1429-1433
[7]   Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates [J].
Fenton, SSA ;
Schaubel, DE ;
Desmeules, M ;
Morrison, HI ;
Mao, Y ;
Copleston, P ;
Jeffery, JR ;
Kjellstrand, CM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (03) :334-342
[8]   Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients [J].
Fleischmann, E ;
Teal, N ;
Dudley, J ;
May, W ;
Bower, JD ;
Salahudeen, AK .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1560-1567
[9]   The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease [J].
Foley, RN ;
Parfrey, PS ;
Harnett, JD ;
Kent, GM ;
Murray, DC ;
Barre, PE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :53-61
[10]   Adapting the Charlson Comorbidity index for use in patients with ESRD [J].
Hemmelgarn, BR ;
Manns, BJ ;
Quan, H ;
Ghali, WA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :125-132